These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

799 related items for PubMed ID: 12414329

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD.
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [Abstract] [Full Text] [Related]

  • 3. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
    Saenz de Tejada I, Angulo J, Cuevas P, Fernández A, Moncada I, Allona A, Lledó E, Körschen HG, Niewöhner U, Haning H, Pages E, Bischoff E.
    Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
    [Abstract] [Full Text] [Related]

  • 4. Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
    Martínez-Salamanca JI, La Fuente JM, Cardoso J, Fernández A, Cuevas P, Wright HM, Angulo J.
    J Sex Med; 2014 May; 11(5):1182-92. PubMed ID: 24877179
    [Abstract] [Full Text] [Related]

  • 5. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications.
    Nehra A, Colreavy F, Khandheria BK, Chandrasekaran K.
    World J Urol; 2001 Feb; 19(1):40-5. PubMed ID: 11289569
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.
    Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM.
    J Urol; 1998 Jun; 159(6):2164-71. PubMed ID: 9598563
    [Abstract] [Full Text] [Related]

  • 8. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
    Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C.
    Int J Impot Res; 1996 Jun; 8(2):47-52. PubMed ID: 8858389
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
    Rosen RC, Kostis JB.
    Am J Cardiol; 2003 Nov 06; 92(9A):9M-18M. PubMed ID: 14609619
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phosphodiesterase 5 mechanisms and therapeutic applications.
    Burnett AL.
    Am J Cardiol; 2005 Dec 26; 96(12B):29M-31M. PubMed ID: 16387563
    [Abstract] [Full Text] [Related]

  • 13. Long-term use of sildenafil.
    Carson CC.
    Expert Opin Pharmacother; 2003 Mar 26; 4(3):397-405. PubMed ID: 12614192
    [Abstract] [Full Text] [Related]

  • 14. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A, Ryder RE.
    Drugs; 2004 Mar 26; 64(23):2667-88. PubMed ID: 15537369
    [Abstract] [Full Text] [Related]

  • 15. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F, Longhurst PA, White MD.
    BJU Int; 2005 Jul 26; 96(1):164-8. PubMed ID: 15963142
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhancement of both EDHF and NO/cGMP pathways is necessary to reverse erectile dysfunction in diabetic rats.
    Angulo J, Cuevas P, Gabancho S, Gonzalez-Corrochano R, Videla S, Saenz de Tejada I.
    J Sex Med; 2005 May 26; 2(3):341-6. PubMed ID: 16422865
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil.
    Pomara G, Morelli G, Pomara S, Taddei S, Ghiadoni L, Dinelli N, Travaglini F, Dicuio M, Mondaini N, Salvetti A, Selli C.
    J Androl; 2004 May 26; 25(4):625-9. PubMed ID: 15223851
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA, Donatucci CF, Hatzichristou D, Torres LO, Valiquette L, Zhao Y, Loughney K, Sides GD, Ahuja S.
    J Sex Med; 2006 Jul 26; 3(4):668-675. PubMed ID: 16839323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.